Details for New Drug Application (NDA): 021443
✉ Email this page to a colleague
The generic ingredient in ENJUVIA is estrogens, conjugated synthetic b. There are three drug master file entries for this compound. Additional details are available on the estrogens, conjugated synthetic b profile page.
Summary for 021443
Tradename: | ENJUVIA |
Applicant: | Aspen |
Ingredient: | estrogens, conjugated synthetic b |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.3MG | ||||
Approval Date: | Dec 20, 2004 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.45MG | ||||
Approval Date: | Dec 20, 2004 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.625MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | May 10, 2004 | TE: | RLD: | No |
Expired US Patents for NDA 021443
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Aspen | ENJUVIA | estrogens, conjugated synthetic b | TABLET;ORAL | 021443-005 | Apr 27, 2007 | ⤷ Sign Up | ⤷ Sign Up |
Aspen | ENJUVIA | estrogens, conjugated synthetic b | TABLET;ORAL | 021443-001 | Dec 20, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Aspen | ENJUVIA | estrogens, conjugated synthetic b | TABLET;ORAL | 021443-002 | Dec 20, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Aspen | ENJUVIA | estrogens, conjugated synthetic b | TABLET;ORAL | 021443-004 | May 10, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Aspen | ENJUVIA | estrogens, conjugated synthetic b | TABLET;ORAL | 021443-003 | May 10, 2004 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription